摘要
β受体阻滞药通过抑制过度激活的交感神经系统,可改善心力衰竭患者的症状,减少住院率和死亡率,改善预后,已成为目前收缩性心力衰竭的标准治疗药物,并得到国内外指南的一致推荐。熟悉β受体阻滞药在心衰治疗中的适应证、禁忌证,掌握其使用方法、药物相互作用、不良反应和处理,以及在特殊人群中的使用原则等,是合理使用这一药物的前提。
13-blockers blocking beta adrenergic receptors lead to symptomatic improvement, reduced hospitalization and enhanced survival. The use of β-blockers becomes now one of the cornerstones in the standard therapy of systolic heart failure, and widely recommended in guidelines. The usage of β-blockers, such as the indications, contraindications, drug nteractions and adverse reactions, as well as in some special patients is presented here
出处
《临床药物治疗杂志》
2012年第6期24-28,共5页
Clinical Medication Journal